Join Us for a Free Webinar on Investing in Cannabis

Join Us for a Free Webinar on Investing in Cannabis

New Frontier Data, in joint efforts with Viridian Capital Advisors, has released Investing in the Cannabis Industry 2017 Edition: Charting the Next Stage in Cannabis Investing Following the Historic 2016 U.S. Elections.

During this webinar, entitled “Investing in Cannabis 2017: Risks and Opportunities”, we will discuss:

  • Investment growth across cannabis industry sectors
  • Number of deals and total capital raised in the industry
  • Market impact under the Trump administration
  • Emerging trends between equity and debt investments
Register for This Free Webinar

About Viridian Capital Advisors, LLC
Viridian Capital Advisors ( is a financial and strategic advisory firm dedicated to the cannabis market. We are a data- and market intelligence-driven firm that provides investment banking, M&A, corporate development, and investor relations services to emerging growth companies and qualified investors in the cannabis sector. Our banking practice, through broker-dealer Pickwick Capital Partners, LLC (Member FINRA/SIPC), provides capital and M&A to fund the growth of our clients, while our advisory practice helps to position and build their businesses. Our team’s decades of high level operating and transactional experience on Wall Street in a variety of emerging sectors, allows Viridian to provide comprehensive strategic and financial solutions that assist cannabis enterprises in realizing their full potential.

Marijuana remains illegal under federal law. The Federal Government does not recognize marijuana to have any medicinal values. Marijuana cultivation, possession, consumption, sales, and distribution are illegal under federal laws and also certain state laws. Please note that there are differences in marijuana laws from one state, county, or city to another.

Harrison Phillips
Vice President
Viridian Capital Advisors, LLC
(212) 209-3086
[email protected]

Facebook Comments

Show More

Related Articles

Leave a Reply